Abbott Laboratories (ABT) Financial Analysis & Valuation | Quarter Chart
Abbott Laboratories (ABT)
ABTPrice: $92.71
Fair Value: 🔒
🔒score
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products... more
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells he... more
Description
Shares
| Market Cap | $161.48B | Exchange | NYSE |
| Sector | Healthcare | Industry | Medical - Devices |
| Country | US | CEO | Robert Ford |
| IPO Date | 1980-03-17 | CAGR | 0.07% |
| Employees | 114,000 | Website | www.abbott.com |
| Div. Yield | 2.55% | Payout Ratio | 0.67% |
| Buy Back Yield | 0.47% | Total Yield | 3.02% |
ABT chart loading...
Fundamentals
Technicals
| Enterprise Value | $215.84B | P/E Ratio | 17.79 |
| Forward P/E | 15.3 | PEG Ratio | -1.32 |
| P/S Ratio | 3.7 | P/B Ratio | 3.21 |
| P/CF Ratio | 17.74 | P/FCF Ratio | 22.69 |
| EPS | $5.21 | EPS Growth 1Y | -53.43% |
| EPS Growth 3Y | 9.12% | EPS Growth 5Y | 12.19% |
| Revenue Growth 1Y | 6.59% | Gross Margin | 0.56% |
| Operating Margin | 0.18% | Profit Margin | 0.14% |
| ROE | 0.12% | ROA | 0.06% |
| ROCE | 0.09% | Current Ratio | 1.39 |
| Quick Ratio | 1.01 | Cash Ratio | 0.37 |
| Debt/Equity | 0.65 | Interest Coverage | 29.83 |
| Altman Z Score | 3.06 | Piotroski Score | 6 |